New Jersey A4957 allows telemedicine and telehealth prescriptions for Schedule II controlled substances without in-person requirements.

New Jersey A4957 revises current law to allow health care providers to prescribe Schedule II controlled dangerous substances through telemedicine or telehealth without requiring an initial in-person examination or subsequent in-person visits every three months. This applies to minor patients under 18, provided the provider uses interactive, real-time, two-way audio and video technologies.

New Jersey A4957 allows telemedicine and telehealth prescriptions for Schedule II controlled substances without in-person requirements.

New Jersey A4957 revises current law to allow health care providers to prescribe Schedule II controlled dangerous substances through telemedicine or telehealth without requiring an initial in-person examination or subsequent in-person visits every three months. This applies to minor patients under 18, provided the provider uses interactive, real-time, two-way audio and video technologies.